Vaccine against COVID-19 or against SARS-CoV-2 infection?

被引：1
作者：
Rieske, Piotr [1 ,2 ]
机构：
[1] Uniwersytet Med Lodzi, Zaklad Biol Nowotwordow, Ul Zeligowskiego 7-9, PL-90752 Lodz, Poland
[2] Celther Polska, Lodz, Poland
来源：
ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY | 2020年 / 7卷 / 03期
关键词：
SARS-CoV-2; vaccine; COVID-19; VIRUS; ANTIBODY; NEUTRALIZATION; MECHANISMS; RESPONSES; PARADIGM;
D O I：
10.5114/pja.2020.97913
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Article offers analysis of main aspects of SARS-CoV-2/COVID-19 vaccination (severe acute respiratory syndrome coronavirus 2/COVID-19-Coronavirus Disease 2019). Optimal vaccine should protect not only against disease COVID-19 (symptoms), but also against SARS-CoV-2 infection (spreading disease). However, this kind of vaccine - showing highest safety level is extremely difficult to get. Several additional SARS-CoV-2/COVID-19 vaccination issues were addressed in article. For example: serological passports, herd immunity, clinical trials, and role of antibodies and T cells crossreactivities. Article discusses some issues related to vaccination responsibilities.
引用
收藏
页码：131 / 145
页数：15
相关论文
共 77 条
[1]   Crippling HIV one mutation at a time [J].
Allen, Todd M. ;
Altfeld, Marcus .
JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (05) :1003-1007
[2]   SARS-CoV-2 Vaccines: Status Report [J].
Amanat, Fatima ;
Krammer, Florian .
IMMUNITY, 2020, 52 (04) :583-589
[3]   Innate and adaptive immune responses to viral infection and vaccination [J].
Aoshi, Taiki ;
Koyama, Shohei ;
Kobiyama, Kouji ;
Akira, Shizuo ;
Ishii, Ken J. .
CURRENT OPINION IN VIROLOGY, 2011, 1 (04) :226-232
[4]   Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review [J].
Bandyopadhyay, Ananda S. ;
Modlin, John F. ;
Wenger, Jay ;
Gast, Chris .
CLINICAL INFECTIOUS DISEASES, 2018, 67 :S35-S41
[5]   Severe acute respiratory syndrome (SARS) -: paradigm of an emerging viral infection [J].
Berger, A ;
Drosten, C ;
Doerr, HW ;
Stürmer, M ;
Preiser, W .
JOURNAL OF CLINICAL VIROLOGY, 2004, 29 (01) :13-22
[6]   Re-infection by COVID-19: a real threat for the future management of pandemia? [J].
Bongiovanni, Marco ;
Basile, Fiorpaolo .
INFECTIOUS DISEASES, 2020, 52 (08) :581-582
[7]   Commensal-Pathogen Interactions along the Human Nasal Passages [J].
Brugger, Silvio D. ;
Bomar, Lindsey ;
Lemon, Katherine P. .
PLOS PATHOGENS, 2016, 12 (07)
[8]   Broadly Neutralizing Antibodies Present New Prospects to Counter Highly Antigenically Diverse Viruses [J].
Burton, Dennis R. ;
Poignard, Pascal ;
Stanfield, Robyn L. ;
Wilson, Ian A. .
SCIENCE, 2012, 337 (6091) :183-186
[9]   Antibodies, viruses and vaccines [J].
Burton, DR .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (09) :706-713
[10]   SARS-CoV-2 infection protects against rechallenge in rhesus macaques [J].
Chandrashekar, Abishek ;
Liu, Jinyan ;
Martinot, Amanda J. ;
McMahan, Katherine ;
Mercado, Noe B. ;
Peter, Lauren ;
Tostanoski, Lisa H. ;
Yu, Jingyou ;
Maliga, Zoltan ;
Nekorchuk, Michael ;
Busman-Sahay, Kathleen ;
Terry, Margaret ;
Wrijil, Linda M. ;
Ducat, Sarah ;
Martinez, David R. ;
Atyeo, Caroline ;
Fischinger, Stephanie ;
Burke, John S. ;
Slein, Matthew D. ;
Pessaint, Laurent ;
Van Ry, Alex ;
Greenhouse, Jack ;
Taylor, Tammy ;
Blade, Kelvin ;
Cook, Anthony ;
Finneyfrock, Brad ;
Brown, Renita ;
Teow, Elyse ;
Velasco, Jason ;
Zahn, Roland ;
Wegmann, Frank ;
Abbink, Peter ;
Bondzie, Esther A. ;
Dagotto, Gabriel ;
Gebre, Makda S. ;
He, Xuan ;
Jacob-Dolan, Catherine ;
Kordana, Nicole ;
Li, Zhenfeng ;
Lifton, Michelle A. ;
Mahrokhian, Shant H. ;
Maxfield, Lori F. ;
Nityanandam, Ramya ;
Nkolola, Joseph P. ;
Schmidt, Aaron G. ;
Miller, Andrew D. ;
Baric, Ralph S. ;
Alter, Galit ;
Sorger, Peter K. ;
Estes, Jacob D. .
SCIENCE, 2020, 369 (6505) :812-+
12345678